Description
Bispecific T-cell engagers (BiTEs) in haematological malignancies
Article: Bispecific T-cell engagers (BiTEs) in haematological malignancies
€3.03
Related products
-
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart
